Rasha O Bara

Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies

Jing Wang, I. Wistuba, J. Heymach, 2017, Oncotarget.

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

Ying Feng, Pan Tong, Robert J. Cardnell, 2017, Oncotarget.

Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers

Jing Wang, Chris Wakefield, L. Byers, 2018, Clinical Cancer Research.

Electrical stimulation to regain lower extremity muscle perfusion and endurance in patients with post‐acute sequelae of SARS CoV‐2: A randomized controlled trial

B. Najafi, Myeounggon Lee, A. Zulbaran-Rojas, 2023, Physiological reports.

Safety and efficacy of electrical stimulation for lower-extremity muscle weakness in intensive care unit 2019 Novel Coronavirus patients: A phase I double-blinded randomized controlled trial

B. Najafi, J. Herlihy, Rasha O. Bara, 2022, Frontiers in Medicine.

The Application of Digital Frailty Screening to Triage Nonhealing and Complex Wounds.

B. Najafi, M. Fernando, A. Zulbaran-Rojas, 2022, Journal of diabetes science and technology.